Overview of Clinical Cytogenetics

Patrick R. Gonzales1, Andrew J. Carroll1, Bruce R. Korf2

1 Cytogenetics Laboratory, Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama, 2 Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama
Publication Name:  Current Protocols in Human Genetics
Unit Number:  Unit 8.1
DOI:  10.1002/0471142905.hg0801s89
Online Posting Date:  April, 2016
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

Chromosome analysis is one of the first approaches to genetic testing and remains a key component of genetic analysis of constitutional and somatic genetic disorders. Numerical or unbalanced structural chromosome abnormalities usually lead to multiple congenital anomalies. Sometimes these are compatible with live birth, usually resulting in severe cognitive and physical handicaps; other times they result in miscarriage or stillbirth. Chromosome rearrangements also occur as somatic changes in malignancies. Identification of constitutional chromosomal anomalies (anomalies present in most or all cells of the body and/or the germline) can provide important information for genetic counseling. In this unit, we introduce chromosomal microarray analysis (CMA), which is a relatively recent addition to cytogenetic technologies, and has become the recommended first‐tier testing method for patients with developmental delay, intellectual disability, autism, and/or multiple congenital anomalies. We also discuss non‐invasive prenatal testing/screening (NIPTS), which uses circulating cell‐free fetal DNA (cfDNA) from maternal plasma to rapidly screen for autosomal and sex‐chromosome aneuploidies. Cytogenetic analysis of tumors is helpful in diagnosis and in monitoring the effects of treatment. The protocols in this chapter cover the clinical study of chromosomes in nonmalignant tissues. © 2016 by John Wiley & Sons, Inc.

Keywords: cytogenetics; chromosomes; microarray; FISH; prenatal; postnatal; constitutional

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Indications for Analysis
  • Molecular Cytogenetic Methods
  • Tissue Sources
  • Chromosome Anomalies
  • LITERATURE CITED
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

LITERATURE CITED
  ACMG (American College of Medical Genetics and Genomics). 2000. Technical and clinical assessment of fluorescence in situ hybridization: An ACMG/ASHG position statement. I. Technical considerations. Genet. Med. 2:356‐361. doi: 10.1097/00125817‐200011000‐00011.
  ACMG (American College of Medical Genetics and Genomics). 2009. Standards and Guidelines for Clinical Genetics Laboratories, Section E: Clinical Cytogenetics. ACMG, Bethesda, Md.
  Auerbach, A.D. 2015. Diagnosis of Fanconi anemia by diepoxybutane analysis. Curr. Protoc. Hum. Genet. 85:8.7.1‐8.7.17. doi: 10.1002/0471142905.hg0807s85.
  Aypar, U., Thorland, E.C., and Hoppman, N. 2013. Prenatal diagnosis of chromosome abnormalities: Past, present, and future. Clin. Chem. 59:1432‐1434. doi: 10.1373/clinchem.2013.204149.
  Bangs, C.D. and Donlon, T.A. 2005. Metaphase chromosome preparation from cultured peripheral blood cells. Curr. Protoc. Hum. Genet. 45:4.1.1‐4.1.19. doi: 10.1002/0471142905.hg0401s45.
  Basehore, M.J. and Friez, M.J. 2014. Molecular analysis of fragile X syndrome. Curr. Protoc. Hum. Genet. 80:9.5.1‐9.5.19. doi: 10.1002/0471142905.hg0905s80.
  Benacerraf, B.R., Gelman, R., and Frigoletto, F.D. 1987. Sonographic identification of second‐trimester fetuses with Down's syndrome. New Engl. J. Med. 317:1371‐1376. doi: 10.1056/NEJM198711263172203.
  Benn, P.A. and Perle, M.A. 1992. Chromosome staining and banding techniques. In Human Cytogenetics: A Practical Approach (D.E. Rooney and B.H. Czepulkowski, eds.) pp. 91‐118. IRL Press, Oxford.
  Bi, W., Borgan, C., Pursley, A., Hixson, P., Shaw, C., Bacino, C., Lalani, S., Patel, A., Stankiewicz, P., Lupski, J., Beaudet, A., and Cheung, S. 2013. Comparison of chromosome analysis and chromosomal microarray analysis: What is the value of chromosome analysis in today's genomic array era? Genet. Med. 15:450‐457. doi: 10.1038/gim.2012.152.
  Borgaonkar, D.S. 2011. Chromosomal Variation in Man, 9th Edition. Wiley‐Liss, New York.
  Boue, J., Boue, A., and Lazar, P. 1973. The epidemiology of human spontaneous abortions with chromosomal anomalies. In Aging Gametes (R.J. Blandau, ed.) pp. 330‐348. S. Karger, Basel.
  Breman, A. and Patel, A. 2012. Preparation of chorionic villus samples for metaphase chromosome analysis and chromosomal microarray analysis. Curr. Protoc. Hum. Genet. 75:8.3.1‐8.3.9. doi: 10.1002/0471142905.hg0803s75.
  Burton, B.K., Schulz, C.J., and Burd, L.I. 1992. Limb anomalies associated with chorionic villus sampling. Obstet. Gynecol. 79:726‐730.
  Canick, J.A. 1990. Screening for Down syndrome using maternal serum α‐fetoprotein, unconjugated estriol, and hCG. J. Clin. Immunoassay 13:30‐33.
  Castle, D. and Bernstein, R. 1988. Cytogenetic analysis of 688 couples experiencing multiple spontaneous abortions. Am. J. Med. Genet. 29:549‐556. doi: 10.1002/ajmg.1320290312.
  Cuckle, H.S., Wald, N.J., and Lindenbaum, R.H. 1984. Maternal serum α‐fetoprotein measurement: A screening test for Down syndrome. Lancet 1:926‐929. doi: 10.1016/S0140-6736(84)92389-4.
  Daniel, A., Hook, E.B., and Wulf, G. 1989. Risks of unbalanced progeny at amniocentesis to carriers of chromosome rearrangements: Data from United States and Canadian laboratories. Am. J. Med. Genet. 33:14‐53. doi: 10.1002/ajmg.1320330105.
  de Grouchy, J. and Turleau, C. 1984. Clinical Atlas of Human Chromosomes, 2nd Edition. John Wiley & Sons, New York.
  DeVries, S., Gray, J.W., Pinkel, D., Waldman, F.M., and Sudar, D. 1995. Comparative genomic hybridization. Curr. Protoc. Hum. Genet. 6:4.6.1‐4.6.18. doi: 10.1002/0471142905.hg0406s06.
  Dharajiya, N., Zwiefelhofer, T., Guan, X., Angkachatchai, V., and Saldivar J.‐S. 2015. Noninvasive prenatal testing using cell‐free fetal DNA in maternal plasma. Curr. Protoc. Hum. Genet. 84:8.15.1‐8.15.20. doi: 10.1002/0471142905.hg0815s84.
  DiMaio, M.S., Baumgarten, A., Greenstein, R.M., Saal, H.M., and Mahoney, M.J. 1987. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum α‐fetoprotein levels. New Engl. J. Med. 317:342‐346. doi: 10.1056/NEJM198708063170603.
  German, J. and Alhadeff, B. 1994. Analysis of sister‐chromatid exchanges. Curr. Protoc. Hum. Genet. 2:8.6.1‐8.6.10. doi: 10.1002/0471142905.hg0806s02.
  Gersen, S.L. and Keagle, M.B. 2013. The Principles of Clinical Cytogenetics, 3rd Edition. Springer Science+Business Media, New York.
  Grist, T.M., Fuller, R.W., Albiez, K.L., and Bowie, J.D. 1990. Femur length in the US prediction of trisomy 21 and other chromosomal abnormalities. Radiology 174:837‐839. doi: 10.1148/radiology.174.3.2137635.
  Haddad, B.R., Schrock, E., Meck, J., Cowan, J., Young, H., Ferguson‐Smith, M.A., du Manoir, S., and Ried, T. 1998. Identification of de novo chromosomal markers and derivatives by spectral karyotyping. Hum. Genet. 103:619‐625. doi: 10.1007/s004390050878.
  Haddow, J.F., Palomaki, G.E., Knight, G., Williams, J., Pulkinnen, A., Canick, J.A., Saller, D.N. Jr., and Bowers, G.B. 1992. Prenatal screening for Down's syndrome with use of maternal serum markers. New Engl. J. Med. 327:588‐593. doi: 10.1056/NEJM199208273270902.
  Hall, J.G. 1990. How imprinting is relevant to human disease. Development 110:141‐148.
  Hardisty, E.E. and Vora, N.L. 2014. Advances in genetic prenatal diagnosis and screening. Curr. Opin. Pediatr. 26:634‐638. doi: 10.1097/MOP.0000000000000145.
  Hook, E. 1987. Issues in analysis of data on paternal age and 47, + 21: Implications for genetic counseling for Down syndrome. Hum. Genet. 77:303‐306. doi: 10.1007/BF00291414.
  Hook, E.B. 1990. Chromosome abnormalities in older women by maternal age: Evaluation of regression‐derived rates in chorionic villus biopsy specimens. Am. J. Med. Genet. 35:184‐187. doi: 10.1002/ajmg.1320350209.
  Hook, E.B., Cross, P.K., and Schreinemachers, M.S. 1983. Chromosomal abnormality rates at amniocentesis and in live‐born infants. J. Am. Med. Assoc. 249:2034‐2038. doi: 10.1001/jama.1983.03330390038028.
  ISCN. 2013. An International System for Human Cytogenetic Nomenclature. (L.G. Shaffer, J. McGowan‐Jordan, and M. Schmid, eds.). S. Karger, Basel.
  Jalal, S.M. and Law, M.E. 1999. Utility of multicolor fluorescence in situ hybridization in clinical cytogenetics. Genet. Med. 1:181‐186. doi: 10.1097/00125817-199907000-00003.
  Josifek, K., Haessig, C., and Pantzar, T. 1991. Evaluation of chromosome banding resolution: A simple guide for laboratory quality assurance. Appl. Cytogenet. 17:101‐105.
  Kalousek, D.K., Barrett, I.J., and Gartner, A.B. 1992. Spontaneous abortion and confined chromosomal mosaicism. Hum. Genet. 88:642‐646. doi: 10.1007/BF02265289.
  Kashork, C.D., Theisen, A., and Shaffer, L.G. 2010. Diagnosis of cryptic chromosomal syndromes by fluorescence in situ hybridization (FISH). Curr. Protoc. Hum. Genet. 67:8.10.1‐8.10.20. doi: 10.1002/0471142905.hg0810s67.
  Knoll, J.H.M. and Lichter, P. 2005. In situ hybridization to metaphase chromosomes and interphase nuclei. Curr. Protoc. Hum. Genet. 45:4.3.1‐4.3.31. doi: 10.1002/0471142905.hg0403s45.
  Korf, B.R. 2010. Current Protocols in Human Genetics. Chapter 10, John Wiley & Sons, Hoboken, N.J.
  Ledbetter, D.H. and Engel, E. 1995. Uniparental disomy in humans: Development of an imprinting map and its implications for prenatal diagnosis. Hum. Mol. Genet. 4:1757‐1764.
  Lee, C., Rens, W., and Yang, F. 2000. Multicolor fluorescence in situ hybridization (FISH) approaches for simultaneous analysis of the entire human genome. Curr. Protoc. Hum. Genet. 24:4.9.1‐4.9.11. doi: 10.1002/0471142905.hg0409s24.
  Levy, B., Dunn, T.M., Kaffe, S., Kardon, N., and Hirschhorn, K. 1998. Clinical applications of comparative genomic hybridization. Genet. Med. 1:4‐12. doi: 10.1097/00125817-199811000-00004.
  Levy, B., Jobanputra, V., and Warburton, D. 2009. Preparation and culture of products of conception and other solid tissues for chromosome analysis. Curr. Protoc. Hum. Genet. 60:8.5.1‐8.5.11. doi: 10.1002/0471142905.hg0805s60.
  Lister, T.J. and Frota‐Pessoa, O. 1980. Recurrence risks for Down syndrome. Hum. Genet. 55:203‐208. doi: 10.1007/BF00291768.
  Lockwood, C.J., Lynch, L., and Berkowitz, R.L. 1991. Ultrasonographic screening for the Down syndrome fetus. Am. J. Obstet. Gynecol. 165:349‐352. doi: 10.1016/0002-9378(91)90090-E.
  Lubs, H.A., Patil, S.A., Kimberling, W.J., Brown, J., Cohen, M., Gerald, P., Hecht, F., Myrianthopoulos, N., and Summitt, R.L. 1977. Q and C banding polymorphisms in 7 and 8 year old children: Racial differences and clinical significance. In Population Cytogenetics. (E.B. Hook and I.H. Porter, eds.), pp. 133‐159. Academic Press, New York.
  MacDonald, I.M. and Cox, D.M. 1985. Inversion of chromosomes 2(p11p13). Frequency and implications for genetic counseling. Hum. Genet. 69:281‐283. doi: 10.1007/BF00293042.
  Martin, C.L. and Ledbetter, D.H. 2015. Molecular cytogenetic analysis of telomere rearrangements. Curr. Protoc. Hum. Genet. 84:8.11.1‐8.11.15. doi: 10.1002/0471142905.hg0811s84.
  McNamara, G., Difilippantonio, M.J., and Ried, T. 2005. Microscopy and image analysis. Curr. Protoc. Hum. Genet. 46:4.4.1‐4.4.34. doi: 10.1002/0471142905.hg0404s46.
  Merkatz, I.R., Nitowsky, H.M., Macri, J.N., and Johnson, W.E. 1984. An association between low maternal serum α‐fetoprotein and fetal chromosomal abnormalities. Am. J. Obstet. Gynecol. 148:886‐894. doi: 10.1016/0002-9378(84)90530-1.
  Miller, D., Adam, M., Aradhya, S., Biesecker, L., Brothman, A., Carter, N., Church, D., Crolla, J., Eichler, E., Epstein, C., Andrew Faucett, W., Feuk, L., Friedman, J., Hamosh, A.,Jackson, L., Kaminsky, E., Kok, K., Krantz, I., Kuhn, R., Lee, C., Ostell, J., Rosenberg, C., Scherer, S., Spinner, N., Stavropoulos, D., Tepperberg, J., Thorland, E., Vermeesch, J., Waggoner, D., Watson, M., Lese Martin, C., and Ledbetter, D. 2010. Consensus statement: Chromosomal microarray is a first‐tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 86:749‐764 doi: 10.1016/j.ajhg.2010.04.006.
  Miller, D.T., Shen, Y., and Wu, B.‐L. 2012. Oligonucleotide microarrays for clinical diagnosis of copy number variation and zygosity status. Curr. Protoc. Hum. Genet. 74:8.12.1‐8.12.17. doi: 10.1002/0471142905.hg0812s74.
  Miron, P. 2012. Preparation, culture, and analysis of amniotic fluid samples. Curr. Protoc. Hum. Genet. 74:8.4.1‐8.4.14. doi: 10.1002/0471142905.hg0804s74.
  Nyberg, D.A., Resta, R.G., Hickok, D.E., Hollenbach, K.A., Luthy, D.A., and Mahony, B.S. 1990. Femur length shortening in the detection of Down syndrome: Is prenatal screening feasible? Am. J. Obstet. Gynecol. 162:1247‐1252. doi: 10.1016/0002-9378(90)90028-6.
  Rhoads, G.G., Jackson, L.G., Shlesselman, S.E., de la Cruz, F.F., Desnick, R.J., Golbus, M.S., Ledbetter, D.H., Lubs, H.A., Mahoney, M.J., Pergament, E., Simpson, J.L., Carpenter, R.J., Elias, S., Ginsberg, N.A., Goldberg, J.D., Hobbins, J.C., Lynch, L., Shiono, P.H., Wapner, R.J., and Zachary, J.M. 1989. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. New Engl. J. Med. 320:609‐617. doi: 10.1056/NEJM198903093201001.
  Sachs, E.S., Jahoda, M.G.J., Los, F.J., Pijpers, L., Reuss, A., and Wladimiroff, J.W. 1990. Interpretation of chromosome mosaicism and discrepancies in chorionic villi studies. Am. J. Med. Genet. 37:268‐271. doi: 10.1002/ajmg.1320370222.
  Schinzel, A. 2001. Catalogue of Unbalanced Chromosome Aberrations in Man, 2nd Edition. Walter de Gruyter, Berlin.
  Schloo, R., Miny, P., Holzgreve, W., Horst, J., and Lenz, W. 1992. Distal limb deficiency following chorionic villus sampling. Am. J. Med. Genet. 42:404‐413. doi: 10.1002/ajmg.1320420338.
  Schreck, R.R. and Distèche, C.M. 1994. Chromosome banding techniques. Curr. Protoc. Hum. Genet. 4.2.1‐4.2.36. doi: 10.1002/0471142905.hg0402s00.
  Schwartz, S. 1993. Efficacy and applicability of interphase fluorescence in situ hybridization for prenatal diagnosis. Am. J. Hum. Genet. 52:851‐853.
  Schwartz, S. and Palmer, C.G. 1983. Chromosomal findings in 164 couples with repeated spontaneous abortions: With special consideration to prior reproductive history. Hum. Genet. 63:28‐34. doi: 10.1007/BF00285393.
  Slavotinek, A., Rosenberg, M., Knight, S., Gaunt, L., Fergusson, W., Killoran, C., Clayton‐Smith, J., Kingston, H., Campbell, R.H., Flint, J., Donnai, D., and Biesecker, L. 1999. Screening for submicroscopic chromosome rearrangements in children with idiopathic mental retardation using microsatellite markers for the chromosome telomeres. J. Med. Genet. 36:405‐411. doi: 10.1136/jmg.36.5.405.
  South, S., Lee, C., Lamb, A., Higgins, A., and Kearney, H. 2013. ACMG Standards and Guidelines for constitutional cytogenomic microarray analysis, including postnatal and prenatal applications: Revision 2013. Genet. Med. 15:901‐909. doi: 10.1038/gim.2013.129.
  Speleman, F., Leroy, J.G., Van Roy, N., de Paepe, A., Suijkerbujik, R., Brunner, H., Looijenga, L., Verschraegen‐Spae, M.‐R., and Orye, E. 1991. Pallister‐Killian syndrome: Characterization of the isochromosome 12p by fluorescent in situ hybridization. Am. J. Med. Genet. 41:381‐387. doi: 10.1002/ajmg.1320410321.
  Stene, E. and Stengel‐Rutkowski, S. 1987. A reanalysis of the New York State prenatal diagnosis data on Down's syndrome and paternal age effects. Hum. Genet. 77:299‐302. doi: 10.1007/BF00291413.
  Tabor, A. and Alfirevic, Z. 2010. Update on procedure‐related risks for prenatal diagnosis techniques. Fetal Diagn. Ther. 27:1‐7 doi: 10.1159/000271995.
  Trimble, B.K. and Baird, P.A. 1978. Maternal age and Down syndrome: Age‐specific incidence rates by single year intervals. Am. J. Med. Genet. 2:1‐5. doi: 10.1002/ajmg.1320020102.
  Wald, N.J. and Cuckle, H.S. 1979. Amniotic fluid α‐fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Lancet 2:652‐661. doi: 10.1016/S0140-6736(79)92065-8.
  Wald, N.J., Cuckle, H.S., and Densem, J.W. 1988. Maternal serum screening for Down's syndrome in early pregnancy. Brit. Med. J. 297:883‐887. doi: 10.1136/bmj.297.6653.883.
  Wilson, M.G., Lin, M.S., Fujimoto, A., Herbert, W., and Kaplan, F.M. 1989. Chromosome mosaicism in 6000 amniocenteses. Am. J. Med. Genet. 32:506‐513. doi: 10.1002/ajmg.1320320417.
  Winston, Y.E. and Horger, E.O., III. 1988. Down syndrome and femur length. Am. J. Obstet. Gynecol. 159:10‐18. doi: 10.1016/S0002-9378(88)80194-7.
  Zahir, F.R. and Marra, M.A. 2015. Use of Affymetrix arrays in the diagnosis of gene copy‐number variation. Curr. Protoc. Hum. Genet. 85:8.13.1‐8.13.13. doi: 10.1002/0471142905.hg0813s85.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library